Global Hemophagocytic Lymphohistiocytosis Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 2.13 Million |
 Market Size (Forecast Year) |
USD 3.18 Million |
 CAGR |
% |
| Major Markets Players |
>全球噬血细胞性淋巴组织细胞增生症市场，按类型（家族性、获得性）、治疗（类固醇、化疗、抗生素、抗病毒药物、其他）、诊断（血液检测、骨髓活检、基因检测、血培养）、给药途径（口服、注射）、分销渠道（医院药房、零售药房、网上药房）、最终用户（医院、家庭护理、专科诊所、其他）划分 - 行业趋势和预测到 2029 年。
市场分析和规模
近年来，噬血细胞性淋巴组织细胞增生症市场预计在预测期内将快速增长。噬血细胞性淋巴组织细胞增生症的发病和严重程度因人而异。发烧、皮疹、肝脏异常增大（肝肿大）和脾脏异常增大是患者（脾肿大）的常见症状。然而，这些早期体征和症状被归类为非特异性。贫血、血小板减少、神经系统症状（如癫痫发作、精神状态改变和易怒）、特定脑神经麻痹（麻痹）以及协调随意运动困难（共济失调）都是患者可能出现的情况。
Data Bridge Market Research 分析称，噬血细胞性淋巴组织细胞增生症市场在 2021 年的价值为 213 万美元，预计到 2029 年将达到 318 万美元，在 2022 年至 2029 年的预测期内复合年增长率为 5.14%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
市场定义
噬血细胞性淋巴组织细胞增生症是一种罕见或危及生命的高炎症血液病，其特征是巨噬细胞异常活化和细胞因子产生增多，导致红细胞吞噬作用、细胞因子介导的组织破坏等多系统表现。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（家族性、获得性）、治疗（类固醇、化疗、抗生素、抗病毒药物等）、诊断（血液检测、骨髓活检、基因检测、血培养）、给药途径（口服、注射）、分销渠道（医院药房、零售药房、网上药房）、最终用户（医院、家庭护理、专科诊所等） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Allergan (Ireland), Merck & Co., Inc. (US), Cipla Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Apotex Inc. (Canada), Amneal Pharmaceuticals LLC. (US), Bristol-Myers Squibb Company (US), Zydus Cadila (India), Gilead Sciences, Inc. (US), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.( Israel), Sanofi (France), Novartis AG (Switzerland), Aurobindo Pharma (India), Lupin (India), Eli Lilly and Company (US) |
|
Market Opportunities |
|
Hemophagocytic Lymphohistiocytosis Market Dynamics
Drivers
- Increasing prevalence of immune-oncology diseases
The rising prevalence of immune-oncology diseases is a major factor driving the hemophagocytic lymphohistiocytosis market's growth. The increasing frequency of immune-oncology diseases resulting in the high risk of developing hemophagocytic lymphohistiocytosis will further propel the 'market's growth rate.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of hemophagocytic lymphohistiocytosis market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the hemophagocytic lymphohistiocytosis market. Additionally, high disposable income and changing lifestyle will expand the hemophagocytic lymphohistiocytosis market. Along with this, rising awareness about diagnosis and treatment of rare diseases for the pediatric population will enhance the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the hemophagocytic lymphohistiocytosis market growth. Along with this, rising drug approvals and launches will further propel the 'market's growth rate.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the hemophagocytic lymphohistiocytosis market during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with treatment and the unavailability of treatment in developing countries will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the hemophagocytic lymphohistiocytosis market. Additionally, the dearth of awareness about the availability of treatment for hemophagocytic lymphohistiocytosis and the absence of standard treatment will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This hemophagocytic lymphohistiocytosis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemophagocytic lymphohistiocytosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Hemophagocytic lymphohistiocytosis is most common in infants and young children, but it can strike anyone. Boys and girls are affected equally. Men are slightly more likely than women to be affected as adults. The actual incidence and prevalence have yet to be determined. The familial type affects about 25% of patients with this illness.
The hemophagocytic lymphohistiocytosis market also provides you with detailed market analysis for patient, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Hemophagocytic Lymphohistiocytosis Market
自 2019 年 12 月出现以来，COVID-19病毒已传播到地球上几乎每个国家，促使世界卫生组织 (WHO) 宣布其为公共卫生紧急事件。由于金融危机和在优先考虑 COVID-19 相关治疗的同时专业医疗服务的延迟，全球医疗保健系统在冠状病毒大流行后受到严重破坏。患者无法看到他们的控制，原因多种多样，包括难以找到医生、害怕感染传播、由于大流行限制而无法继续治疗和基本程序。这些考虑可能会对近几个月的噬血细胞性淋巴组织细胞增生症市场产生负面影响。
全球噬血细胞性淋巴组织细胞增生症市场范围
噬血细胞性淋巴组织细胞增生症市场根据类型、治疗、诊断、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
治疗
- 类固醇
- 化疗
- 抗生素
- 抗病毒药物
- 其他的
根据治疗方法，市场分为类固醇、化疗、抗生素、抗病毒药物和其他药物。
给药途径
- 口服
- 注射剂
全球噬血细胞性淋巴组织细胞增生症市场的给药途径分为口服和注射。
类型
- 家庭
- 获得性
根据类型，市场分为家庭型和获得型。
诊断
- 血液检查
- 骨髓活检
- 基因检测
- 血培养
根据诊断，市场分为血液测试、骨髓活检、基因检测和血液培养。
最终用户
- 医院
- 专科诊所
- 家庭护理
- 其他的
根据最终用户，噬血细胞性淋巴组织细胞增生症市场分为医院、专科诊所、家庭护理和其他。
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
根据分销渠道，噬血细胞性淋巴组织细胞增生症市场也细分为医院药房、零售药房、网上药房和其他。
噬血细胞性淋巴组织细胞增生症市场区域分析/见解
对噬血细胞性淋巴组织细胞增生症市场进行了分析，并按国家、类型、治疗、诊断、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
噬血细胞性淋巴组织细胞增生症市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区
北美在噬血细胞性淋巴组织细胞增生症市场中占据主导地位，因为该地区出血性疾病的患病率不断上升，且医疗费用不断增加。此外，新技术的采用率不断提高，对疾病特异性治疗的需求不断增加，将进一步推动该地区市场的增长速度。
由于癌症病例数量的增加和主要参与者的存在，预计欧洲在预测期内将实现增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和噬血细胞性淋巴组织细胞增生症市场份额分析
噬血细胞性淋巴组织细胞增生症市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对噬血细胞性淋巴组织细胞增生症市场的关注有关。
噬血细胞性淋巴组织细胞增生症市场的一些主要参与者包括：
- 艾尔建（爱尔兰）
- 默克公司（美国）
- Cipla Inc.（美国）
- 太阳制药工业有限公司 (印度)
- Apotex Inc.（加拿大）
- Amneal Pharmaceuticals LLC.（美国）
- 百时美施贵宝公司 (美国)
- Zydus Cadila（印度）
- 吉利德科学公司（美国）
- 辉瑞公司（美国）
- 葛兰素史克公司 (英国)
- 雅培（美国）
- F. Hoffmann-La Roche Ltd.（瑞士）
- Mylan NV（美国）、Teva Pharmaceutical Industries Ltd.（以色列）
- 赛诺菲（法国）
- 诺华公司（瑞士）
- Aurobindo Pharma（印度）
- 鲁冰花（印度）
- 礼来公司 (美国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
